166 related articles for article (PubMed ID: 37659675)
1. TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
Rubenstein JH; Stachler MD
Gastroenterology; 2023 Nov; 165(5):1106-1107. PubMed ID: 37659675
[No Abstract] [Full Text] [Related]
2. Comments on "TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?".
Duits LC; Critchley-Thorne RJ; Bergman JJGHM
Gastroenterology; 2024 Apr; 166(4):714-715. PubMed ID: 38109947
[No Abstract] [Full Text] [Related]
3. Predictive biomarkers for Barrett's esophagus: so near and yet so far.
Timmer MR; Sun G; Gorospe EC; Leggett CL; Lutzke L; Krishnadath KK; Wang KK
Dis Esophagus; 2013 Aug; 26(6):574-81. PubMed ID: 23316980
[TBL] [Abstract][Full Text] [Related]
4. Barrett's esophagus and Barrett's carcinoma.
von Rahden BH; Stein HJ; Siewert JR
Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
[TBL] [Abstract][Full Text] [Related]
5. Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.
Sami SS; Ragunath K; Iyer PG
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):623-34. PubMed ID: 24887058
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
McManus DT; Olaru A; Meltzer SJ
Cancer Res; 2004 Mar; 64(5):1561-9. PubMed ID: 14996709
[TBL] [Abstract][Full Text] [Related]
7. Barrett's Esophagus.
Bujanda DE; Hachem C
Mo Med; 2018; 115(3):211-213. PubMed ID: 30228724
[TBL] [Abstract][Full Text] [Related]
8. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
9. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus.
Souza RF; Spechler SJ
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):105-115. PubMed ID: 33213790
[TBL] [Abstract][Full Text] [Related]
10. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
[TBL] [Abstract][Full Text] [Related]
11. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
12. Surveillance in Barrett's esophagus: a failed premise.
Inadomi JM
Keio J Med; 2009 Mar; 58(1):12-8. PubMed ID: 19398879
[TBL] [Abstract][Full Text] [Related]
13. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
Spechler SJ
Med Clin North Am; 2002 Nov; 86(6):1423-45, vii. PubMed ID: 12510459
[TBL] [Abstract][Full Text] [Related]
14. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
15. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
16. [Barrett's esophageal cancer].
Makuuchi H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):161-8. PubMed ID: 11865619
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
Dent J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
[TBL] [Abstract][Full Text] [Related]
18. Agrin Loss in Barrett's Esophagus-Related Neoplasia and Its Utility as a Diagnostic and Predictive Biomarker.
Rickelt S; Neyaz A; Condon C; Whittaker CA; Zaidi AH; Taylor MS; Abbruzzese G; Mattia AR; Zukerberg L; Shroff SG; Yilmaz OH; Yilmaz O; Wu EY; Choi WT; Jobe BA; Odze RD; Patil DT; Deshpande V; Hynes RO
Clin Cancer Res; 2022 Mar; 28(6):1167-1179. PubMed ID: 34785582
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
[TBL] [Abstract][Full Text] [Related]
20. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
De Backer AI; De Schepper AM; Pelckmans P
Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
